Molecular Characteristics and Peptide Specificity of Vasoactive Intestinal Peptide Receptors from Rat Cerebral Cortex
- 1 November 1986
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 47 (5) , 1469-1475
- https://doi.org/10.1111/j.1471-4159.1986.tb00780.x
Abstract
Vasoactive intestinal peptide (VIP) receptors have been identified in CNS by their chemical specificity and molecular size. Using synaptosomes isolated from rat cerebral cortex, it was shown that central VIP receptors discriminated among natural and synthetic VIP-related peptides, because half-maximal inhibition of [125I]VIP binding to synaptosomes was obtained for 0.6 nM VIP, 9 nM peptide histidine isoleucineamide (PHI), 50 nM VIP 2–28, 70 nM secretin, 100 nM rat growth hormone-releasing factor (GRF), and 350 nM human GRF. Other peptides of the VIP family, such as glucagon and gastric inhibitory polypeptide, did not interact with cortical VIP receptors. The molecular components of VIP receptors in rat cerebral cortex were identified after [125I]VIP cross-linking to synaptosomes using the cross-linker dithiobis(succinimidyl propionate). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of synaptosomal proteins revealed two major [125I]VIP-pro-tein complexes of Mr 49,000 and 18,000. The labeling of the Mr49,000 component was specific, because it was abolished by native VIP, whereas the labeling of the Mr 18,000 component was not. Natural VIP agonists reduced the labeling of the Mr49,000 component with the following order of potency: VIP > PHI > secretin ∼ rat GRF. In contrast, glucagon and octapeptide of cholecystokinin were without effect, a result indicating its peptide specificity. Densitometric scanning of autoradiographs showed that the labeling of the Mr 49,000 component was inhibited by low VIP concentrations between 10−-10 and 10−-6M (IC50= 0.8 nM), a result indicating the component's high affinity for VIP. Labeling was also reduced by GTP in the concentration range between 10−-7 and 10−-3M (ED50= 5 μM). Assuming that one molecule of [125I]VIP is bound per molecule of synaptosomal protein, a major protein of Mr 46,000 was identified as a component of the VIP receptor in rat cerebral cortex.Keywords
This publication has 37 references indexed in Scilit:
- The Human Vasoactive Intestinal Peptide Receptor: Molecular Identification by Covalent Cross-Linking in Colonic Epithelium*Journal of Clinical Endocrinology & Metabolism, 1985
- Vasoactive Intestinal Polypeptide Receptors Linked to an Adenylate Cyclase, and Their Relationship with Biogenic Amine‐ and Somatostatin‐Sensitive Adenylate Cyclases on Central Neuronal and Glial Cells in Primary CulturesJournal of Neurochemistry, 1985
- The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptorBiochemical Journal, 1985
- Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: Effect of nine partial sequencesBiochemical and Biophysical Research Communications, 1984
- Activators of cyclic adenosine 3':5'-monophosphate accumulation in rat hippocampal slices: action of vasoactive intestinal peptide (VIP)Journal of Neuroscience, 1983
- Multiplicity of receptors for vasoactive intestinal polypeptide (VIP): Differential effects of apamin on binding in brain, uterus and liverPeptides, 1983
- Porcine peptide having N‐terminal histidine and C‐terminal isoleucine amide (PHI)FEBS Letters, 1980
- Vasoactive intestinal polypeptide (VIP) stimulates adenylate cyclase in selected areas of rat brainLife Sciences, 1979
- Characterization of VIP-sensitive adenylate cyclase in guinea pig brainFEBS Letters, 1977
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976